163 related articles for article (PubMed ID: 19632930)
1. Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor.
Bhattacharya A; Tóth K; Sen A; Seshadri M; Cao S; Durrani FA; Faber E; Repasky EA; Rustum YM
Clin Colorectal Cancer; 2009 Jul; 8(3):155-62. PubMed ID: 19632930
[TBL] [Abstract][Full Text] [Related]
2. Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs.
Bhattacharya A; Seshadri M; Oven SD; Tóth K; Vaughan MM; Rustum YM
Clin Cancer Res; 2008 Jun; 14(12):3926-32. PubMed ID: 18559614
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.
Bhattacharya A; Tóth K; Durrani FA; Cao S; Slocum HK; Chintala S; Rustum YM
Neoplasia; 2008 Aug; 10(8):857-65. PubMed ID: 18670644
[TBL] [Abstract][Full Text] [Related]
4. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
Chintala S; Tóth K; Cao S; Durrani FA; Vaughan MM; Jensen RL; Rustum YM
Cancer Chemother Pharmacol; 2010 Oct; 66(5):899-911. PubMed ID: 20066420
[TBL] [Abstract][Full Text] [Related]
5. Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
Li Z; Carrier L; Belame A; Thiyagarajah A; Salvo VA; Burow ME; Rowan BG
Breast Cancer Res Treat; 2009 Nov; 118(1):33-43. PubMed ID: 18855134
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis.
Yin MB; Li ZR; Tóth K; Cao S; Durrani FA; Hapke G; Bhattacharya A; Azrak RG; Frank C; Rustum YM
Oncogene; 2006 Apr; 25(17):2509-19. PubMed ID: 16518418
[TBL] [Abstract][Full Text] [Related]
7. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.
Bhattacharya A; Tóth K; Mazurchuk R; Spernyak JA; Slocum HK; Pendyala L; Azrak R; Cao S; Durrani FA; Rustum YM
Clin Cancer Res; 2004 Dec; 10(23):8005-17. PubMed ID: 15585636
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.
Bhattacharya A; Turowski SG; San Martin ID; Rajput A; Rustum YM; Hoffman RM; Seshadri M
Anticancer Res; 2011 Feb; 31(2):387-93. PubMed ID: 21378316
[TBL] [Abstract][Full Text] [Related]
9. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.
Cao S; Durrani FA; Rustum YM
Clin Cancer Res; 2004 Apr; 10(7):2561-9. PubMed ID: 15073137
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells.
Sinha R; Kiley SC; Lu JX; Thompson HJ; Moraes R; Jaken S; Medina D
Cancer Lett; 1999 Nov; 146(2):135-45. PubMed ID: 10656618
[TBL] [Abstract][Full Text] [Related]
11. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
12. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.
Unni E; Koul D; Yung WK; Sinha R
Breast Cancer Res; 2005; 7(5):R699-707. PubMed ID: 16168115
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent.
Azrak RG; Cao S; Pendyala L; Durrani FA; Fakih M; Combs GF; Prey J; Smith PF; Rustum YM
Biochem Pharmacol; 2007 May; 73(9):1280-7. PubMed ID: 17239826
[TBL] [Abstract][Full Text] [Related]
15. Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation.
Azrak RG; Cao S; Durrani FA; Toth K; Bhattacharya A; Rustum YM
Cancer Lett; 2011 Dec; 311(2):219-29. PubMed ID: 21872389
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors.
Azrak RG; Yu J; Pendyala L; Smith PF; Cao S; Li X; Shannon WD; Durrani FA; McLeod HL; Rustum YM
Mol Cancer Ther; 2005 May; 4(5):843-54. PubMed ID: 15897249
[TBL] [Abstract][Full Text] [Related]
17. Methylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs.
Bhattacharya A
Expert Opin Drug Deliv; 2011 Jun; 8(6):749-63. PubMed ID: 21473705
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence.
Luetzkendorf J; Mueller LP; Mueller T; Caysa H; Nerger K; Schmoll HJ
J Cell Mol Med; 2010 Sep; 14(9):2292-304. PubMed ID: 19508388
[TBL] [Abstract][Full Text] [Related]
19. Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer.
Wei TT; Lin YT; Tang SP; Luo CK; Tsai CT; Shun CT; Chen CC
Oncogene; 2020 Jan; 39(2):414-427. PubMed ID: 31477841
[TBL] [Abstract][Full Text] [Related]
20. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
